日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Graft-Versus-Leukemia Effect in the Management of Isolated Pancreatic Granulocytic Sarcoma Following Allogeneic Stem Cell Transplantation

异基因造血干细胞移植后孤立性胰腺粒细胞肉瘤治疗中的移植物抗白血病效应

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.90072
Kurt, Ramazan; Aydin, Yucel; Kalayoglu Besisik, Sevgi
细胞生物学
发育与干细胞
白血病
干细胞
粒细胞
发表日期：2025
文献求助 收藏

Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic

COVID-19 中高炎症反应的诊断标准：对来自疫情不同时期的两个队列的分析

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.42417
Amikishiyev, Shirkhan; Gunver, M Guven; Bektas, Murat; Aghamuradov, Sarvan; Ince, Burak; Koca, Nevzat; Torun, Ege Sinan; Aliyeva, Numune; Sari, Selma; Cetin, Cigdem; Yalcin-Dulundu, Banu C; Deniz, Rabia; Kemik, Fatih; Agargun, Besim Fazil; Gulseren, Ubeyde Ayse; Besisik, Beliz; Alkan, Onur; Bagriacik, Ceren; Tor, Yavuz B; Senkal, Naci; Catma, Yunus; Durak, Gorkem; Mese, Sevim; Agacfidan, Ali; Kose, Murat; Erelel, Mustafa; Cagatay, A Atahan; Simsek-Yavuz, Serap; Kalayoglu-Besisik, Sevgi; Esen, Figen; Gül, Ahmet
炎症/感染
炎症
发表日期：2023
文献求助 收藏

Blood and bone marrow donor registry of Istanbul medical faculty activity and experience in past 3 years : A cross-sectional documentation of TRIS activity: the first blood and marrow registry in Turkey

伊斯坦布尔医学院血液和骨髓捐献者登记处过去三年的活动和经验：TRIS 活动的横断面记录：土耳其首个血液和骨髓登记处

期刊:Cell and Tissue Banking
影响因子:2
doi:10.1007/s10561-021-09967-z
Savran Oguz, Fatma; Erol, Ayse; Kekik Cinar, Cigdem; Kivanc, Demet; Suleymanoglu, Mediha; Ogret, Yeliz; Senturk Ciftci, Hayriye; Kalayoglu Besisik, Sevgi
发表日期：2022
文献求助 收藏

Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma

复发/难治性套细胞淋巴瘤单药来那度胺II期研究的长期分析

期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.24854
Witzig, Thomas E; Luigi Zinzani, Pier; Habermann, Thomas M; Tuscano, Joseph M; Drach, Johannes; Ramchandren, Radhakrishnan; Kalayoglu Besisik, Sevgi; Takeshita, Kenichi; Casadebaig Bravo, Marie-Laure; Zhang, Lei; Fu, Tommy; Goy, Andre
淋巴瘤
细胞生物学
发表日期：2017
文献求助 收藏

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial

MCL-001（EMERGE）关键性试验中，接受来那度胺治疗的复发/难治性套细胞淋巴瘤患者的长期随访和肿瘤细胞增殖率（Ki-67）预后

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.13456
Goy, Andre; Kalayoglu Besisik, Sevgi; Drach, Johannes; Ramchandren, Radhakrishnan; Robertson, Michael J; Avivi, Irit; Rowe, Jacob M; Herbrecht, Raoul; Van Hoof, Achiel; Zhang, Lei; Cicero, Sherri; Fu, Tommy; Witzig, Thomas
Ki-67
肿瘤
肿瘤免疫
淋巴瘤
ERG
细胞生物学
肿瘤细胞
发表日期：2015
文献求助 收藏

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study

单药来那度胺治疗对硼替佐米治疗后复发、进展或耐药的套细胞淋巴瘤患者：II期MCL-001（EMERGE）研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2013.49.2835
Goy, Andre; Sinha, Rajni; Williams, Michael E; Kalayoglu Besisik, Sevgi; Drach, Johannes; Ramchandren, Radhakrishnan; Zhang, Lei; Cicero, Sherri; Fu, Tommy; Witzig, Thomas E
ERG
细胞生物学
淋巴瘤
发表日期：2013
文献求助 收藏

Leukemic ascites as an initial presentation of acute myelomonocytic leukemia with inversion of chromosome 16

16号染色体倒位急性髓单核细胞白血病的首发表现为白血病性腹水

期刊:
影响因子:
doi:10.5144/0256-4947.2013.197
Yonal, Ipek; Kayar, Yusuf; Nazligul, Esra; Yenerel, Mustafa Nuri; Kalayoglu-Besisik, Sevgi
白血病
细胞生物学
单核细胞
发表日期：2013
文献求助 收藏